Valbiotis SA (FR:ALVAL) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Valbiotis, a French company focusing on the development of dietary supplements to combat metabolic disorders and cardiovascular diseases, has reported their total number of voting rights and shares as of June 30, 2024. The company, known for its innovative, plant-based approach, markets its products in France and seeks international licensing agreements. Valbiotis is part of the BPI Excellence network and has received European Union funding for research.
For further insights into FR:ALVAL stock, check out TipRanks’ Stock Analysis page.